Isoimperatorin attenuates bone loss by inhibiting the binding of RANKL to RANK.
Li H, Deng W, Qin Q, Lin Y, Liu T, Mo G, Shao Y, Tang Y, Yuan K, Xu L, Li Y, Zhang S.
Li H, et al. Among authors: shao y.
Biochem Pharmacol. 2023 May;211:115502. doi: 10.1016/j.bcp.2023.115502. Epub 2023 Mar 13.
Biochem Pharmacol. 2023.
PMID: 36921635
Free article.